ストックスクリーナーアプリを入手
0.0712
5.94%
-0.0045
アフターアワーズ：
.07
-0.0012
-1.69%
Conduit Pharmaceuticals Inc (CDT) 最新ニュース
Stock Plummets to Cents. Can the Company Bounce Back? - Jomfruland.net
Conduit Pharmaceuticals faces Nasdaq delisting over price, votes for reverse split - Investing.com
Conduit Pharmaceuticals Faces Nasdaq Delisting, Plans Stock Split - TipRanks
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics - The Manila Times
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial - The Bakersfield Californian
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and - EIN News
Conduit Pharmaceuticals files to sell 75M shares of common stock for holders - MSN
Conduit Pharmaceuticals issues convertible note, amends Nirland agreement - Investing.com
Conduit Pharmaceuticals issues convertible note, amends Nirland agreement By Investing.com - Investing.com Canada
What's Going On With Conduit Pharmaceuticals Shares Today? - Benzinga
Stock market today: SCWorx Corp. gains 141.81% while Pyxis Oncology down by 46.41% in early trading - Business Upturn
Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders - The Manila Times
Conduit Pharmaceuticals receives further patent approval for AZD1656 - TipRanks
Conduit Pharma Secures Key Patent for Autoimmune Drug AZD1656 in Major Japan Market | CDT Stock News - StockTitan
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsight - The Malaysian Reserve
Conduit Pharmaceuticals reshuffles board and amends bylaws - Investing.com
Conduit Pharmaceuticals reshuffles board and amends bylaws By Investing.com - Investing.com UK
Conduit Pharmaceuticals Announces Leadership Changes and Bylaws Update - TipRanks
Conduit Pharmaceuticals Strengthens Board with 30-Year Investment Banking Veteran Simon Fry | CDT Stock News - StockTitan
Conduit Pharmaceuticals announces restatement of financials - Investing.com
Pre-market Movers: GANX, TFFP, AKYA, CLDI... - RTTNews
Remitly Global Inc (NASDAQ: RELY) Is The Number One Stock Currently Moving. - Stocks Register
Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews
Conduit Pharmaceuticals announces new addition to autoimmune pipeline - Yahoo Finance
Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline - StockTitan
Conduit Pharmaceuticals Opens New Lab Space In Cambridge, UK - Contract Pharma
Conduit Pharmaceuticals secures $1.2 million in funding - Investing.com India
Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes - The Manila Times
Conduit Pharmaceuticals secures $1.2 million in funding By Investing.com - Investing.com South Africa
Conduit Pharmaceuticals announces debt restructuring and additional notes - MSN
LeMaitre to Participate at Upcoming Investor Conferences in November - The Manila Times
Conduit Pharmaceuticals Secures Funding and Modifies Debt Agreements - TipRanks
Lexicon Pharmaceuticals Loses Over A Third Of Its Market Cap Post FDA Vote On Drug: Retail Sentiment Sours - MSN
Prologis Inc (NYSE: PLD): Forecast Strong In 2024, Up 18.49% - Stocks Register
Where Do Analysts Think The Conduit Pharmaceuticals Inc (NASDAQ: CDT) Is Going - Stocks Register
Presidio Property Trust Provides Update on Model Home Activity in Q3 2024 - The Manila Times
Conduit Pharmaceuticals announces debt restructuring By Investing.com - Investing.com Australia
Conduit Pharmaceuticals announces debt restructuring - Investing.com India
CDT Stock on the Rise: A Promising Investment - The InvestChronicle
Conduit Pharmaceuticals Inc [CDT] Insider Nirland Ltd sells 1,500,000 Shares – Insider Selling Alert - Knox Daily
Investing in Capricor Therapeutics Inc (CAPR): What You Must Know - Knox Daily
A stock that deserves closer examination: Conduit Pharmaceuticals Inc (CDT) - US Post News
CDT’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Selling Buzz: Conduit Pharmaceuticals Inc [CDT] 10% Owner Nirland Ltd sells 1,500,000 shares of the company - Knox Daily
Astrazeneca PLC Reports 9.9% Passive Stake In Conduit Pharmaceuticals Inc As Of August 7SEC Filing - XM
There is no way Conduit Pharmaceuticals Inc (CDT) can keep these numbers up - SETE News
Conduit Pharmaceuticals Inc’s latest rating changes from various analysts - Knox Daily
Ltd Nirland Sells 939,009 Shares of Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Stock - Defense World
Conduit Pharmaceuticals insiders sell shares worth over $393k By Investing.com - Investing.com South Africa
Conduit Pharmaceuticals insiders sell shares worth over $393k - Investing.com
Market cap of Conduit Pharmaceuticals Inc [CDT] reaches 9.50M – now what? - The DBT News
Examining Conduit Pharmaceuticals Inc (CDT) more closely is necessary - US Post News
Balance Sheet Dive: Conduit Pharmaceuticals Inc (CDT)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
0.60%
2.24%
大文字化:
|
ボリューム (24 時間):